Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia

Abstract Background To determine the hypnotic and analgesic effects of brimonidine, and evaluate its efficacy and safety for general anesthesia. Potentiation of pentobarbital sleeping time following brimonidine administration was observed in mice, as was the analgesic activity of brimonidine. Method...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen Bin, Wang Xiaohui, Shi Mengrou, Li Xin, Zhang Ting, Gao Ping
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/cfd17b14d75d4b80a29846ae55d4eb14
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cfd17b14d75d4b80a29846ae55d4eb14
record_format dspace
spelling oai:doaj.org-article:cfd17b14d75d4b80a29846ae55d4eb142021-12-05T12:07:57ZPreliminary evaluation of the efficacy and safety of brimonidine for general anesthesia10.1186/s12871-021-01516-11471-2253https://doaj.org/article/cfd17b14d75d4b80a29846ae55d4eb142021-12-01T00:00:00Zhttps://doi.org/10.1186/s12871-021-01516-1https://doaj.org/toc/1471-2253Abstract Background To determine the hypnotic and analgesic effects of brimonidine, and evaluate its efficacy and safety for general anesthesia. Potentiation of pentobarbital sleeping time following brimonidine administration was observed in mice, as was the analgesic activity of brimonidine. Methods The median effective dose (ED50) and lethal dose (LD50) of intraperitoneally injected brimonidine were determined in hypnotized mice. In addition, the LD50 of intravenously injected brimonidine, and ED50 of intravenously, intramuscularly, and intrarectally injected brimonidine in hypnotized rabbits were determined. Finally, the synergistic anesthetic effect of brimonidine and chloral hydrate was evaluated in rabbits. Results Intraperitoneal injection of 10 mg/kg brimonidine enhanced the hypnotic effect of a threshold dose of pentobarbital. Intraperitoneally injected brimonidine produced dose-related analgesic effects in mice. The ED50 of intraperitoneally administered brimonidine in hypnotized mice was 75.7 mg/kg and the LD50 was 379 mg/kg. ED50 values of intravenous, intramuscular, and intrarectal brimonidine for hypnosis in rabbits were 5.2 mg/kg, 8.8 mg/kg, and 8.7 mg/kg, respectively; the LD50 of intravenous brimonidine was 146 mg/kg. Combined intravenous administration of 0.6 mg/kg brimonidine and 0.03 g/kg chloral hydrate had a synergistic anesthetic effect. Conclusions Brimonidine elicited hypnotic and analgesic effects after systemic administration and exhibited safety. Moreover, brimonidine enhanced the effects of other types of narcotics when combined.Chen BinWang XiaohuiShi MengrouLi XinZhang TingGao PingBMCarticleBrimonidine tartrateAdrenergic alpha-2 receptor agonistsGeneral anesthesiaLethal dose 50Effective dose 50AnesthesiologyRD78.3-87.3ENBMC Anesthesiology, Vol 21, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Brimonidine tartrate
Adrenergic alpha-2 receptor agonists
General anesthesia
Lethal dose 50
Effective dose 50
Anesthesiology
RD78.3-87.3
spellingShingle Brimonidine tartrate
Adrenergic alpha-2 receptor agonists
General anesthesia
Lethal dose 50
Effective dose 50
Anesthesiology
RD78.3-87.3
Chen Bin
Wang Xiaohui
Shi Mengrou
Li Xin
Zhang Ting
Gao Ping
Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia
description Abstract Background To determine the hypnotic and analgesic effects of brimonidine, and evaluate its efficacy and safety for general anesthesia. Potentiation of pentobarbital sleeping time following brimonidine administration was observed in mice, as was the analgesic activity of brimonidine. Methods The median effective dose (ED50) and lethal dose (LD50) of intraperitoneally injected brimonidine were determined in hypnotized mice. In addition, the LD50 of intravenously injected brimonidine, and ED50 of intravenously, intramuscularly, and intrarectally injected brimonidine in hypnotized rabbits were determined. Finally, the synergistic anesthetic effect of brimonidine and chloral hydrate was evaluated in rabbits. Results Intraperitoneal injection of 10 mg/kg brimonidine enhanced the hypnotic effect of a threshold dose of pentobarbital. Intraperitoneally injected brimonidine produced dose-related analgesic effects in mice. The ED50 of intraperitoneally administered brimonidine in hypnotized mice was 75.7 mg/kg and the LD50 was 379 mg/kg. ED50 values of intravenous, intramuscular, and intrarectal brimonidine for hypnosis in rabbits were 5.2 mg/kg, 8.8 mg/kg, and 8.7 mg/kg, respectively; the LD50 of intravenous brimonidine was 146 mg/kg. Combined intravenous administration of 0.6 mg/kg brimonidine and 0.03 g/kg chloral hydrate had a synergistic anesthetic effect. Conclusions Brimonidine elicited hypnotic and analgesic effects after systemic administration and exhibited safety. Moreover, brimonidine enhanced the effects of other types of narcotics when combined.
format article
author Chen Bin
Wang Xiaohui
Shi Mengrou
Li Xin
Zhang Ting
Gao Ping
author_facet Chen Bin
Wang Xiaohui
Shi Mengrou
Li Xin
Zhang Ting
Gao Ping
author_sort Chen Bin
title Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia
title_short Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia
title_full Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia
title_fullStr Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia
title_full_unstemmed Preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia
title_sort preliminary evaluation of the efficacy and safety of brimonidine for general anesthesia
publisher BMC
publishDate 2021
url https://doaj.org/article/cfd17b14d75d4b80a29846ae55d4eb14
work_keys_str_mv AT chenbin preliminaryevaluationoftheefficacyandsafetyofbrimonidineforgeneralanesthesia
AT wangxiaohui preliminaryevaluationoftheefficacyandsafetyofbrimonidineforgeneralanesthesia
AT shimengrou preliminaryevaluationoftheefficacyandsafetyofbrimonidineforgeneralanesthesia
AT lixin preliminaryevaluationoftheefficacyandsafetyofbrimonidineforgeneralanesthesia
AT zhangting preliminaryevaluationoftheefficacyandsafetyofbrimonidineforgeneralanesthesia
AT gaoping preliminaryevaluationoftheefficacyandsafetyofbrimonidineforgeneralanesthesia
_version_ 1718372220466626560